Colorectal Cancer Clinical Trial
Official title:
Impact of Water-assisted Colonoscopy vs Second Forward View Examination of the Right Colon on Adenoma Detection
Introduction and objectives: The adenoma detection rate (ADR) has been investigated as a
formal method in the evaluation of a trainee or resident physician. Several studies have
suggested that water-assisted colonoscopy methods increase the ADR, especially in the right
colon, when compared to air-insufflated methods alone. The objective of this study is to
compare the adenoma detection rates between the techniques of the second frontal view
examination and "Underwater" examination by residents, supervised by a senior endoscopist.
Patients and methods: This is a prospective, comparative and randomized clinical trial. The
patients referred to the Cancer Hospital of Barretos for colonoscopy, and who agreed with the
study, were divided into two groups, one with the use of water and the other only with air
insufflation. The primary endpoint of this study is to compare adenoma detection rate.
Secondary outcomes were withdrawal time, proportion of intubation of the cecum, preparation
of the colon, and number of previously performed colonoscopies in the ADR in both techniques.
| Status | Not yet recruiting |
| Enrollment | 708 |
| Est. completion date | November 1, 2018 |
| Est. primary completion date | June 1, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Patients undergoing diagnostic colonoscopy and surveillance colonoscopy Exclusion Criteria: - Contraindication for performing the endoscopic procedure. - Refusal to provide inform consent. - Past history of partial colectomy, familial adenomatous polyposis, inflammatory bowel disease, coagulopathy or thrombocytopenia. - Incomplete colonoscopy - Inadequate bowel preparation - Pregnant patients. |
| Country | Name | City | State |
|---|---|---|---|
| Brazil | Denise Guimaraes | Barretos | SÃO Paulo |
| Lead Sponsor | Collaborator |
|---|---|
| Barretos Cancer Hospital |
Brazil,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Adenoma detection rate | Proportion of individuals with at least one adenoma | up to 12 months | |
| Secondary | Detection rate of any clinically significant lesion | Proportion of participants with at least one clinically significant lesion (adenoma, serrated or cancer) | up to 12 months | |
| Secondary | Detection rate of serrated adenoma | Proportion of participants with at least one serrated adenoma total and per resident | up to 12 monthas | |
| Secondary | Colonoscopy completion rate per resident | Proportion of complete colonoscopies per resident, independently of the senior examiner | up to 12 months | |
| Secondary | Cecal intubation time | Time it takes from anal insertion ti the time the tip of colonoscope in the the cecum | up to 12 months | |
| Secondary | Colonoscopy withdrawal time | time it takes to withdraw colonoscope | up to 12 months | |
| Secondary | Boston Intestinal Preparation Scale | Proportion of participants with boston scale grade | up to 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |